Back

The Lancet Regional Health - Europe

32 training papers 2019-06-25 – 2026-03-07

Top medRxiv preprints most likely to be published in this journal, ranked by match strength.

1
SGLT2 inhibitor use in type 2 diabetes in England: a population-based cohort study of uptake of NICE guidance
2026-02-05 epidemiology 10.64898/2026.02.04.26343917
#1 (1.9%)
Show abstract

ObjectivesAn update to the NICE Type 2 diabetes (T2DM) guideline in February 2022 recommended an SGLT2 inhibitor be offered to people with heart failure (HF) or cardiovascular disease (CVD) as comorbidities and considered for people at high CVD risk. We report uptake of this guideline in England by September 2023. DesignObservational cohort study. SettingGeneral practices contributing to the Clinical Practice Research Data Link, linked to hospital admission records. Participants587,826 people...

2
Spatiotemporal Trends in Suicide: Sociodemographic, Economic, and Environmental Factors
2026-03-05 epidemiology 10.64898/2026.03.04.26347568
#1 (1.9%)
Show abstract

Suicide is one of the worlds leading public health problems, with more than 720,000 deaths annually. Suicide has traditionally been studied from an individual perspective. However, research has increasingly highlighted the influence of community-level factors on suicide risk. This study aimed to (1) analyse the spatial distribution of suicide mortality at the provincial level in Spain (2018-2022); (2) perform stratified analyses by sex and age group; and (3) compare suicide risk across differen...

3
The Hidden Burden of Mortality Across the Spectrum of ICD-10 Conditions in Australia: A Multiple Cause of Death Analysis
2026-02-09 epidemiology 10.64898/2026.02.07.26345820
Top 0.1% (1.8%)
Show abstract

BackgroundDeath certificates record both an underlying cause and contributing conditions, yet mortality statistics predominantly report only the underlying cause. We quantify this "hidden burden" across all ICD-10 conditions in Australian mortality data using the multiple-to-underlying ratio (MUR): total death certificate mentions divided by underlying cause deaths. MethodsWe analysed Australian Bureau of Statistics Causes of Death 2023 data (N = 187,268 registered deaths) to compute the ratio ...

4
Associations of childhood body composition trajectories and adolescent body dissatisfaction: Longitudinal evidence from the UK Millennium Cohort Study
2025-12-14 epidemiology 10.64898/2025.12.10.25342007
Top 0.1% (1.8%)
Show abstract

PurposeBody dissatisfaction is common, particularly among those with higher BMIs. Issues with BMI as an adiposity measure may limit our understanding of body dissatisfaction determinants. We investigate the association of childhood trajectories of BMI, fat mass index (FMI), and fat-free mass index (FFMI) with body dissatisfaction at age 14, and sex differences in these associations. MethodsWe used latent class growth analysis to model trajectories of BMI (3-14 years), FMI and FFMI (7-14 years) ...

5
Association of birth weight centiles with infant and child growth dynamics
2026-01-13 epidemiology 10.64898/2026.01.10.26343435
Top 0.2% (1.8%)
Show abstract

ImportanceInfants born small or large for gestational age exhibit different growth patterns compared with appropriate-for-gestational age counterparts. Evidence is lacking on how birth weight centiles beyond conventional thresholds predict early life growth. ObjectiveQuantify association of birth weight centile range with infant and child growth. DesignProspective cohort study. SettingFrance, Netherlands, Portugal, Singapore, United Kingdom, United States. ParticipantsSingletons from seven b...

6
A Time-to-Event Comparison of Immune and Endocrine Biomarkers and Latent Profiles in Hospitalisation: An Outcome-wide Approach
2026-01-11 epidemiology 10.64898/2026.01.09.26343800
Top 0.2% (1.8%)
Show abstract

Background. Early identification of risk for hospitalisation is crucial to reducing public health burden. Immune and endocrine-related markers are robust indicators of disease in epidemiological studies, but their value has not been consistently established with severe disorders requiring hospitalisation. Patterning of biomarker expression through latent profile analysis (LPA), may improve predictive accuracy for clinical outcomes above individual biomarkers alone. Method. Four biomarkers (C-rea...

7
Reducing mental health inequalities through hypothetical interventions in early childhood: Evidence from mediation analysis using the UK Millennium Cohort Study
2026-01-08 epidemiology 10.64898/2026.01.07.26343647
Top 0.2% (1.8%)
Show abstract

The early childhood environment influences later mental health, but it remains unclear which aspects are most important for reducing inequalities. We quantified how socioeconomic inequalities in mental health at 5 and 17 years (y) would change under hypothetical interventions on five aspects of the early childhood environment. We analysed parent-reported data from the UK Millennium Cohort Study (n=15513). Socioeconomic circumstances (SEC) were assessed using maternal education at 9 months. Menta...

8
Dietary sugar exposure in early life and risk of adult mental health disorders: UK Biobank cohort study
2026-01-22 epidemiology 10.64898/2026.01.20.26344391
Top 0.2% (1.7%)
Show abstract

Recent findings suggest that sugar rationing during the first 1000 days of life may influence chronic disease risk in adulthood. Given the link between mental health and non-communicable diseases, early-life sugar restriction may be associated with later-life incidence of anxiety and depression. Using UK Biobank data, participants born between October 1, 1951, and March 31, 1956 (n = 46,448) were grouped by duration of exposure to sugar rationing: R270 (rationed from conception to 270 days of li...

9
Prevalence of 406 rare diseases by ethnicity and their associated COVID-19 infection burden: A national cross-sectional study of 62.5 million people in England
2026-01-16 public and global health 10.64898/2026.01.13.26344068
Top 0.3% (1.5%)
Show abstract

BackgroundThe COVID-19 pandemic disproportionately affected vulnerable populations, including individuals with rare diseases (RDs) and, in the general population, those from ethnic minority backgrounds. However, the intersectional risk, and how these vulnerabilities combine, is poorly understood. A comprehensive baseline map of RD prevalence by granular ethnicity is required to investigate the pandemics true impact on these complex patient groups. MethodsThis study had two aims: (1) to generate...

10
Secondary Prevention of Cardiovascular Events in Patients with Overweight/Obesity in Routine Clinical Practice
2026-02-20 epidemiology 10.64898/2026.02.18.26346594
Top 0.3% (1.5%)
Show abstract

Background and AimsThe glucagon-like peptide-1 receptor agonist (GLP-1 RA) semaglutide has demonstrated efficacy for the secondary prevention of cardiovascular disease among patients with overweight/obesity without diabetes mellitus. However, the comparative effectiveness of GLP-1 RA versus other antiobesity medications (e.g. phentermine-topiramate) not been evaluated. MethodsThis was a retrospective, observational, cohort study using target trial emulation methodology using the Truveta electro...

11
Mortality risk by age 22 in young people with neurodisability in England: a national cohort study using linked health and education data
2026-01-13 epidemiology 10.64898/2026.01.12.26343912
Top 0.3% (1.4%)
Show abstract

BackgroundAdolescence and early adulthood are periods of increased mortality risk, and young people with neurodisability may be particularly vulnerable, yet evidence on mortality during the transition from paediatric to adult services is limited. ObjectivesTo estimate all-cause and cause-specific mortality risk from ages 11 to 22 years in young people with and without neurodisability in England. MethodsWe used the Education and Child Health Insights from Linked Data (ECHILD) database to follow...

12
Assessing the impact of the COVID-19 pandemic on routine childhood vaccination uptake in the Netherlands
2026-02-20 epidemiology 10.64898/2026.02.19.26346601
Top 0.4% (1.4%)
Show abstract

BackgroundInitial reports from the Netherlands indicate a decline in routine childhood vaccination uptake during and after the COVID-19 pandemic, with emerging evidence of reduced parental vaccine confidence. This study aimed to evaluate the long-term impact of the COVID-19 pandemic on routine childhood vaccination uptake. MethodsWe conducted a retrospective nationwide cohort study including all children born in the Netherlands in 2016-2024. First-dose DTaP-IPV vaccination status by age six mon...

13
Trends in Cardiometabolic Disease and Health-Related Quality of Life in the United States, 2001-2022
2026-02-23 health economics 10.64898/2026.02.20.26346754
Top 0.4% (1.3%)
Show abstract

ObjectivesTo examine associations between cardiometabolic conditions and health-related quality of life (HRQoL) and to evaluate whether condition-associated HRQoL changed from 2001 to 2022. MethodsWe analyzed nationally representative data from U.S. adults aged [≥]18 years in the Medical Expenditure Panel Survey, 2001-2022. Survey years without BMI data (2017, 2019, 2021) were excluded. EQ-5D utilities were mapped from SF-12 scores using a validated algorithm. For each survey year, survey-we...

14
Comparative Cardiovascular Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors in Diabetes Mellitus
2026-02-24 endocrinology 10.64898/2026.02.23.26346890
Top 0.4% (1.3%)
Show abstract

BackgroundGLP-1 receptor agonists (GLP-1RAs) and SGLT2 inhibitors (SGLT2Is) have established cardiovascular benefits for patients with type 2 diabetes mellitus (T2DM), with similar class-level effectiveness found in previous studies. However, real-world comparative effectiveness assessments of individual agents remain limited. ObjectivesTo compare the cardiovascular effectiveness of individual GLP-1RAs and SGLT2Is. MethodsWe conducted a multi-national, retrospective, new-user active-comparator...

15
Personal-MetaboHealth, an actionable health check in middle age, is improved by an effective lifestyle intervention in those at risk
2026-02-17 public and global health 10.64898/2026.02.15.26346369
Top 0.5% (1.3%)
Show abstract

The biomarker MetaboHealth represents a novel indicator of overall health in middle age and may potentially be suitable as actionable health check in prevention strategies. MetaboHealth is a blood-based metabolomic composite score that predicts a wide range of age-related conditions and mortality in large European cohorts. Here, we investigated whether MetaboHealth can be personalised and limited to clinically validated metabolomic markers. Next, we assessed whether the updated MetaboHealth scor...

16
The age paradox in post-infectious sequelae: physiological reserve outweighs chronological age in Long COVID susceptibility
2026-02-26 public and global health 10.64898/2026.02.24.26346989
Top 0.5% (1.3%)
Show abstract

BackgroundOlder age is widely considered a risk factor for post-acute sequelae of SARS-CoV-2 infection (PASC), typically attributed to immunosenescence and inflammaging. However, whether this association reflects intrinsic biological ageing or accumulated comorbidity burden remains unclear, with implications for clinical risk stratification. MethodsWe conducted a retrospective cohort study using the Precision PASC Research Cohort (P2RC) from Mass General Brigham, comprising 133,792 COVID-19 pat...

17
Assessing the Impact of the Healthy Vaccinee Effect on COVID-19 Vaccine Effectiveness Estimates
2026-01-03 epidemiology 10.64898/2026.01.02.26343330
Top 0.5% (1.3%)
Show abstract

BackgroundHealth status influences uptake of COVID-19 vaccination, with vaccinated individuals generally being healthier than their unvaccinated counterparts. However, the extent to which this healthy vaccinee effect biases vaccine effectiveness estimates remains unclear. This study investigated how different levels of the healthy vaccinee effect may impact these estimates. MethodsThree national, matched, retrospective cohort studies were conducted on the population of Qatar from February 5, 20...

18
Associations between disease-specific polygenic risk scores and disease-specific causes of death in the UK Biobank cohort
2025-12-23 epidemiology 10.64898/2025.12.21.25342770
Top 0.5% (1.3%)
Show abstract

1.Disease-specific Polygenic Risk Scores (PRS) are usually evaluated against the incidence of diseases they were derived for. Individuals may be more interested in how these PRS influence their probable cause of death. Using UK Biobank data, we examined the top 10 causes of death among individuals in the highest quintile of disease-specific PRS for Alzheimers disease, bowel cancer, cardiovascular disease, coronary artery disease, ischaemic stroke, breast cancer, epithelial ovarian cancer, and pr...

19
Youth in crisis: comparative geographies of suicide between Argentina, Chile, Spain and Uruguay
2026-02-12 public and global health 10.64898/2026.02.06.26345682
Top 0.5% (1.3%)
Show abstract

IntroductionNational trends in youth suicide risk may mask significant regional variations within a country. This article attempts to account for spatio-temporal trends through a comparative analysis across South America and Europe. This paper analyzes the spatiotemporal patterns in suicide mortality among young people (10-29 years) in Argentina, Chile, Spain, and Uruguay during the period 1997-2021. MethodsOfficial data from vital statistics and population censuses of the four countries were a...

20
Monitoring influenza-like symptoms in the UK through participatory surveillance: insights from FluSurvey over two winter seasons (2023-24 and 2024-25)
2026-02-15 public and global health 10.64898/2026.02.12.26345150
Top 0.6% (1.3%)
Show abstract

FluSurvey is a participatory surveillance system used to monitor trends in influenza and other respiratory viruses through weekly symptom surveys among the UK population. We aimed to characterise the wider impact of "influenza-like illnesses" (ILI) among FluSurvey participants and assess correlations of ILI with other established influenza surveillance systems. We included data reported by FluSurvey participants over the 2023-24 and 2024-25 winter seasons. Using weekly symptoms surveys, we deri...